利用壳聚糖微囊化多柔比星

Q2 Pharmacology, Toxicology and Pharmaceutics
José Puertas, Arianne López, Francisco González Cazorla, Manuel Giménez Labrador, Mattias Adrian Repetto Baubin, Manuel José Lis Arias
{"title":"利用壳聚糖微囊化多柔比星","authors":"José Puertas, Arianne López, Francisco González Cazorla, Manuel Giménez Labrador, Mattias Adrian Repetto Baubin, Manuel José Lis Arias","doi":"10.2174/0122103031255282231117053143","DOIUrl":null,"url":null,"abstract":"For some medical treatments associated with cancer, the invasion of organs is required, which must be done in a totally controlled way to obtain the expected results in the treatment. Today, most medical treatments make use of invasive therapies to combat the affected cancer tissues. Acting in this way also destroys those tissues not affected by the generation of tumor centers that confront the cancer tumor center to be treated. To ensure the objective of the treatment, doses of the drug to be administered in a little controlled and free via are used that are ultimately ineffective due to the high degradation of the active compound due to its non-existent stabilization and protection after its passage through the body and consequently possible episodes of phagocytization, responsible for the reticuloendothelial system. It is well known the side effects that one of the most promising anti-cancer molecules, doxorubicin, shows. This is a problem for its use, and one of the possibilities to avoid these desired behaviors, microencapsulation could be a possible approach. Microencapsulation of drugs allows the design of micro-level structures capable of containing the active agent with sufficient protection and stabilization to be able to reach the target site with the highest possible concentration of drug to be able to be gradually released in its entirety and produce the desired effect in the therapy in a controlled way according to a previously studied kinetic profile, which will allow a type of treatment in which the therapy will be noninvasive due to the high degree of targeting selectivity that the microcapsule allows. The use of the amine groups present in the chitosan polymer's structure to increase or modify the molecular interactions with doxorubicin is a very interesting aspect that will be treated here. These interactions help to make possible the control and protection of the active principle, as it is shown in the quantification of the drug-delivery behavior of the system made.","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":"77 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microencapsulation of Doxorubicin using Chitosan\",\"authors\":\"José Puertas, Arianne López, Francisco González Cazorla, Manuel Giménez Labrador, Mattias Adrian Repetto Baubin, Manuel José Lis Arias\",\"doi\":\"10.2174/0122103031255282231117053143\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"For some medical treatments associated with cancer, the invasion of organs is required, which must be done in a totally controlled way to obtain the expected results in the treatment. Today, most medical treatments make use of invasive therapies to combat the affected cancer tissues. Acting in this way also destroys those tissues not affected by the generation of tumor centers that confront the cancer tumor center to be treated. To ensure the objective of the treatment, doses of the drug to be administered in a little controlled and free via are used that are ultimately ineffective due to the high degradation of the active compound due to its non-existent stabilization and protection after its passage through the body and consequently possible episodes of phagocytization, responsible for the reticuloendothelial system. It is well known the side effects that one of the most promising anti-cancer molecules, doxorubicin, shows. This is a problem for its use, and one of the possibilities to avoid these desired behaviors, microencapsulation could be a possible approach. Microencapsulation of drugs allows the design of micro-level structures capable of containing the active agent with sufficient protection and stabilization to be able to reach the target site with the highest possible concentration of drug to be able to be gradually released in its entirety and produce the desired effect in the therapy in a controlled way according to a previously studied kinetic profile, which will allow a type of treatment in which the therapy will be noninvasive due to the high degree of targeting selectivity that the microcapsule allows. The use of the amine groups present in the chitosan polymer's structure to increase or modify the molecular interactions with doxorubicin is a very interesting aspect that will be treated here. These interactions help to make possible the control and protection of the active principle, as it is shown in the quantification of the drug-delivery behavior of the system made.\",\"PeriodicalId\":11310,\"journal\":{\"name\":\"Drug Delivery Letters\",\"volume\":\"77 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Delivery Letters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0122103031255282231117053143\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0122103031255282231117053143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

有些与癌症有关的医学治疗需要侵入器官,必须在完全可控的情况下进行,才能取得预期的治疗效果。如今,大多数医疗方法都使用侵入性疗法来对付受影响的癌症组织。这种方法也会破坏那些未受肿瘤中心产生影响的组织,而这些肿瘤中心正与要治疗的癌症肿瘤中心对峙。 为了确保达到治疗目的,需要使用一些剂量的药物,这些药物在通过人体后,由于不存在稳定和保护作用,活性化合物会高度降解,从而可能导致负责网状内皮系统的吞噬作用的发生。众所周知,最有前途的抗癌分子之一多柔比星会产生副作用。这是使用多柔比星的一个问题,而微胶囊技术则是避免这些副作用的可行方法之一。 药物的微胶囊化可以设计出能够包含活性药物的微型结构,这种结构具有足够的保护性和稳定性,能够以尽可能高的药物浓度到达靶点,并根据先前研究的动力学曲线,以可控的方式逐渐释放出全部药物,在治疗中产生预期的效果,由于微胶囊具有高度的靶向选择性,这种治疗方式将是非侵入性的。 利用壳聚糖聚合物结构中的胺基团来增加或改变与多柔比星的分子相互作用是一个非常有趣的方面,这里将对其进行讨论。这些相互作用有助于控制和保护活性成分,这一点在对所制系统的给药行为进行量化时可以看出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Microencapsulation of Doxorubicin using Chitosan
For some medical treatments associated with cancer, the invasion of organs is required, which must be done in a totally controlled way to obtain the expected results in the treatment. Today, most medical treatments make use of invasive therapies to combat the affected cancer tissues. Acting in this way also destroys those tissues not affected by the generation of tumor centers that confront the cancer tumor center to be treated. To ensure the objective of the treatment, doses of the drug to be administered in a little controlled and free via are used that are ultimately ineffective due to the high degradation of the active compound due to its non-existent stabilization and protection after its passage through the body and consequently possible episodes of phagocytization, responsible for the reticuloendothelial system. It is well known the side effects that one of the most promising anti-cancer molecules, doxorubicin, shows. This is a problem for its use, and one of the possibilities to avoid these desired behaviors, microencapsulation could be a possible approach. Microencapsulation of drugs allows the design of micro-level structures capable of containing the active agent with sufficient protection and stabilization to be able to reach the target site with the highest possible concentration of drug to be able to be gradually released in its entirety and produce the desired effect in the therapy in a controlled way according to a previously studied kinetic profile, which will allow a type of treatment in which the therapy will be noninvasive due to the high degree of targeting selectivity that the microcapsule allows. The use of the amine groups present in the chitosan polymer's structure to increase or modify the molecular interactions with doxorubicin is a very interesting aspect that will be treated here. These interactions help to make possible the control and protection of the active principle, as it is shown in the quantification of the drug-delivery behavior of the system made.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Delivery Letters
Drug Delivery Letters Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.70
自引率
0.00%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信